Curtis Gale Oltmans

General Counsel, ARRAY BIOPHARMA INC.

Companies

AVENUE THERAPEUTICS, INC.Board member Dec 21, 2021 to now¹
Fulcrum Therapeutics (United States)General counsel Dec 7, 2020 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Fulcrum Therapeutics (United States) FULC10,252 shares³$37.9K at $3.70Dec 15, 2025
AVENUE THERAPEUTICS, INC. ATXI49,020 shares⁴$21.1K at $0.43Dec 17, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 15, 2025Sold 3,452 shares at $12.92 of Fulcrum Therapeutics (United States)³
Dec 17, 2021Granted 49,020 shares of AVENUE THERAPEUTICS, INC.⁴
Dec 17, 2021Gift 1,088 shares of Fulcrum Therapeutics (United States)⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAVENUE THERAPEUTICS, INC., Board member
2
SEC EDGARFulcrum Therapeutics (United States), General counsel
3
SEC EDGARFulcrum Therapeutics (United States) shares after the filing of Dec 15, 2025
4
SEC EDGARAVENUE THERAPEUTICS, INC. shares after the filing of Dec 17, 2021
5
SEC EDGARForm 5 filed Jan 7, 2022